DPP-4-IN-18
DPP-4-IN-18 (Sitagliptin impurity 3) (Compound 4) impurity 3 is a potent, selective and orally active DPP-4 inhibitor with an IC50 of 27 nM. DPP-4-IN-18 can effectively prevent DPP-4 from degrading glucagon-like peptide 1 (GLP-1), thereby increasing the level of active GLP-1. DPP-4-IN-18 can be used for the research of type 2 diabetes[1].
Product Specifications
CAS Number
486460-31-5
Product Name Alternative
Sitagliptin impurity 3
UNSPSC
12352005
Hazard Statement
H319-H373
Target
Dipeptidyl Peptidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=CC=C3F
Molecular Formula
C16H16F5N5O
Molecular Weight
389.32
Precautions
P260-P264-P280-P305+P351+P338-P501
References & Citations
[1]Thornberry NA, et al. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Curr Top Med Chem. 2007;7 (6) :557-68.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Isoform
DPP-4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OKAG00349-96W 12x 8 Well Microstrips
OKAG00349-96W - p53 (Phospho-Ser20) DNA-Binding ELISA Kit
Sign In for Pricing
View Details